Virtual RealiTy and mUsic in the Oncology SEtting - Phase 1

The VRtuose (Virtual RealiTy and mUsic in the Oncology Setting) project aims to evaluate the feasibility of implementing in day patient chemotherapy units a distraction strategy combining virtual reality (VR) and music which fits the needs of both breast cancer patients and healthcare providers (i.e., strategy administrators), and to evaluate its impact on patients' (i) perceived anxiety and pain during chemotherapy sessions, (ii) nausea/vomiting and mood disturbances in between chemotherapy sessions, and (iii) quality of life. The present project is a non-randomized non-controlled prospective monocentric feasibility study which will focus on evaluating the feasibility of implementing the strategy in the target population and setting. In the case that implementation of a distraction strategy combining virtual reality and music to improve quality of life of breast cancer patients during chemotherapy is deemed feasible, the efficacy of using this strategy to improve patients' experience of chemotherapy and long-term quality of life will be evaluated in a future randomized controlled trial informed and optimized by the results of the present work.

Sex

Female

Minimum age

18 Years

Inclusion Criteria:

* Histologically confirmed diagnosis of breast cancer;
* Any disease stage;
* Patient must be receiving (i.e., with at least 4 remaining cures) or about to start palliative or curative neoadjuvant or adjuvant chemotherapy for their breast cancer at Centre Léon Bérard;
* Willingness and ability to comply with the study requirements;
* Patient must be covered by a medical insurance;
* Patient must understand, speak, read and write French.

Exclusion Criteria:

* History of condition contraindicating the use of virtual reality (e.g., epilepsy, severe motion sickness);
* Brain metastases;
* Any medical or psychosocial condition that would compromise the patient's compliance to the study procedures or would likely interfere with the completion of Patient-Reported Outcomes;
* Patients under tutorship or curatorship;
* Patients already included in another clinical trial ongoing at Centre Léon Bérard.